The Difficile-Associated Diarrhea Treatment market was valued at USD 2.90 Billion in 2022 and is expected to reach USD 7.18 Billion by 2030, growing at a CAGR of 12% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.